Report
EUR 13.94 For Business Accounts Only

FLEURY sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of FLEURY (BR), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date September 24, 2021, the closing price was BRL 23.20 and its potential was estimated at BRL 26.85.
Underlying
Fleury SA

Fleury SA, formerly Laboratorio de Analises e Pesquisas Clinicas SC Ltda, is a Brazil-based company engaged in the provision of medical laboratory services. The Company's activities are divided into three business segments: Diagnostic medicine, Integrated medicine and Dental. The Diagnostic medicine division provides clinical analysis and diagnostic imaging in partner hospitals. The Integrated medicine division offers private medical diagnostics, as well as tests for laboratories, hospitals and clinics. The Dental division focuses on dental diagnostic imaging. The Company provides services in Brazil through a number of brand names, such as Fleury, Felippe Mattoso, Weinmann, a+ Medicina Diagnostica, Labs a+, Diagnoson a+ and Papaiz.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch